Journal
CLINICAL INFECTIOUS DISEASES
Volume 75, Issue SUPPL 1, Pages S5-S10Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac301
Keywords
COVID-19 vaccine; clinical trials; study design; pandemic preparedness
Categories
Funding
- Sanofi
- Merck
- Pfizer
- Lilly
- Quidel
Ask authors/readers for more resources
This article reviews the importance of vaccine clinical trials in developing effective COVID-19 vaccines. It highlights the challenges of supply chain disruptions, infection control, study designs, and participant factors, as well as specific solutions to streamline the clinical trial process.
Vaccine clinical trials were essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors are reviewed, along with ways to streamline the clinical trial process. Vaccine clinical trials have been essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors that affect trial procedures are reviewed, with specific solutions to streamline the clinical trial process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available